This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXNPEC0K08U_M.jpg
Thermo Fisher Scientific announced earnings per share of $5.08 on revenue of $10.68. Analysts polled by Investing.com anticipated EPS of $4.81 on revenue of $9.92B.
Thermo Fisher Scientific shares are down 22% from the beginning of the year, still down 23.46% from its 52 week high of $672.34 set on December 31, 2021.
Thermo Fisher Scientific’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
